GDP Non-Compliance Report for Czech Company D-Pharm
Recommendation

8 September 2026
Basel, Switzerland
Specifics in the Distribution of Medicinal Products
On 21st July 2015 the competent authority of the Czech Republic has issued a EU GDP Non-Compliance report to a wholesale distributor. According to that report the company D-Pharm located at Makovského námestí 2, Brno, 616 00 does not comply with the Good Distribution Practice requirements.
As the report filed in EudraGMDP (the EU wide GMP and GDP compliance database) mentions, the company D-Pharm seriously violated the conditions on which its permission for activities is based, and they fell short of the obligations set out in § 77 of the Act on Pharmaceuticals. Further details on the concrete GDP findings have not been published.
Source EudraGMDP Database
Related GMP News
18.06.2026GDPA Participated as an Observer in the EMA GMDP-IWG Interested Parties Meeting
18.06.2026Questions and Answers from the ECA Webinar "GDP Update 2026" - Part 4
18.06.2026GDP Non-Compliance Report: Missed CAPA Timelines lead to Refusal of GDP Certificate
17.06.2026European GDP Association Developments January through April 2026
12.05.2026How Are Service Providers Qualified in a GDP Environment?
12.05.2026Questions and Answers from the ECA Webinar "GDP Update 2026" - Part 3


